The stock of Alignment Healthcare Inc (ALHC) has gone up by 6.64% for the week, with a 18.67% rise in the past month and a 71.77% rise in the past quarter. The volatility ratio for the week is 3.59%, and the volatility levels for the past 30 days are 4.83% for ALHC. The simple moving average for the past 20 days is 12.29% for ALHC’s stock, with a 59.11% simple moving average for the past 200 days.
Is It Worth Investing in Alignment Healthcare Inc (NASDAQ: ALHC) Right Now?
The stock has a 36-month beta value of 1.32. Opinions on the stock are mixed, with 8 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for ALHC is 106.32M, and at present, short sellers hold a 7.78% of that float. On April 01, 2025, the average trading volume of ALHC was 2.17M shares.
ALHC) stock’s latest price update
The stock price of Alignment Healthcare Inc (NASDAQ: ALHC) has surged by 1.75 when compared to previous closing price of 18.30, but the company has seen a 6.64% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-02-28 that Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants John Kao – Founder & Chief Executive Officer Thomas Freeman – Chief Financial Officer Conference Call Participants Scott Fidel – Stephens Adam Ron – Bank of America Michael Ha – Baird Matthew Gillmor – KeyBanc Capital Markets Jessica Tassan – Piper Sandler Operator Good afternoon, and welcome to Alignment Healthcare’s Fourth Quarter 2024 Earnings Conference Call and Webcast. [Operator Instructions].
Analysts’ Opinion of ALHC
Many brokerage firms have already submitted their reports for ALHC stocks, with Stephens repeating the rating for ALHC by listing it as a “Overweight.” The predicted price for ALHC in the upcoming period, according to Stephens is $17 based on the research report published on December 03, 2024 of the previous year 2024.
BofA Securities gave a rating of “Buy” to ALHC, setting the target price at $11 in the report published on May 30th of the previous year.
ALHC Trading at 21.06% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 0.98% of gains for the given period.
Volatility was left at 4.83%, however, over the last 30 days, the volatility rate increased by 3.59%, as shares surge +19.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +27.97% upper at present.
During the last 5 trading sessions, ALHC rose by +6.64%, which changed the moving average for the period of 200-days by +125.42% in comparison to the 20-day moving average, which settled at $16.58. In addition, Alignment Healthcare Inc saw 65.51% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from Scavo Robert L., who sale 2,864 shares at the price of $17.89 back on Mar 27 ’25. After this action, Scavo Robert L. now owns 702,953 shares of Alignment Healthcare Inc, valued at $51,237 using the latest closing price.
Kardes Hakan, the Chief Experience Officer of Alignment Healthcare Inc, sale 7,225 shares at $17.89 during a trade that took place back on Mar 27 ’25, which means that Kardes Hakan is holding 678,987 shares at $129,255 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.04 for the present operating margin
- 0.11 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.05. The total capital return value is set at -0.24. Equity return is now at value -99.72, with -18.64 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at 4.44. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is -4.31.
Currently, EBITDA for the company is -77.44 million with net debt to EBITDA at 5.49. When we switch over and look at the enterprise to sales, we see a ratio of 1.16. The receivables turnover for the company is 17.57for trailing twelve months and the total asset turnover is 3.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.88.
Conclusion
To sum up, Alignment Healthcare Inc (ALHC) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
